Contact Us
Subscribe
E-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Site search

73°
- Borger, TX (79008)
  Today
  
  Mostly cloudy with heavy rain ending overnight. Low 58F. Winds SSE at 15 to 25 mph. Chance of rain 100%. Rainfall possibly over one inch..
  
  Tonight
  
  Mostly cloudy with heavy rain ending overnight. Low 58F. Winds SSE at 15 to 25 mph. Chance of rain 100%. Rainfall possibly over one inch.
  
  Updated: May 21, 2026 @ 5:27 pm
- Full Forecast

Home
News
- Local News
Sports
Entertainment
Obituaries
e-Edition
Classifieds
- Place an ad
- Classified Display Ads
Best of 2026
Archives
Announcements

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

INmune Bio Inc. - Common stock (NQ:INMB)

1.440 +0.030 (+2.13%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about INmune Bio Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 Next >

INmune Bio's Return On Capital Employed Insights ↗

March 09, 2022

INmune Bio (NASDAQ:INMB) brought in sales totaling $163.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 2.25%, resulting in a loss of...

Via Benzinga

INmune Bio: Q4 Earnings Insights ↗

March 03, 2022

INmune Bio (NASDAQ:INMB) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings INmune...

Via Benzinga

The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO ↗

March 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis...

Via Benzinga

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗

February 27, 2022

Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...

Via Benzinga

Earnings Scheduled For March 3, 2022 ↗

March 03, 2022

Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 18, 2022

Gainers Biofrontera (NASDAQ:BFRA) stock moved upwards by 11.8% to $3.49 during Friday's pre-market session. The market value of their outstanding shares is at $98.9...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 17, 2022

Gainers NeuroOne Medical Tech (NASDAQ:NMTC) shares moved upwards by 12.3% to $3.0 during Thursday's pre-market session. The company's market cap stands at $48.5...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 09, 2022

Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 13.6% to $1.25 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.1...

Via Benzinga

INmune Bio, Inc. (INMB) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

INMB earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

92 Biggest Movers From Friday ↗

November 08, 2021

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 25, 2021

Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar...

Via Benzinga

Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market ↗

October 21, 2021

Cortexyme is testing a twice-day pill to treat Alzheimer's disease.

Via Investor's Business Daily

Inmune Bio Stock Flashes Robust RS Rating ↗

September 22, 2021

On Wednesday, Inmune Bio stock saw its Relative Strength Rating jump into the 90-plus percentile, to 92 from 85 the day before.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 08, 2021

Gainers Kadmon Holdings (NASDAQ:KDMN) shares increased by 72.64% to $9.15 during Wednesday's regular session. Trading volume for Kadmon Holdings's stock is 95.3...

Via Benzinga

54 Biggest Movers From Yesterday ↗

September 09, 2021

Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday. Helbiz, Inc. (NASDAQ: HLBZ) gained 84% to...

Via Benzinga

30 Stocks Moving In Wednesday's Mid-Day Session ↗

September 08, 2021

Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion...

Via Benzinga

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week ↗

September 05, 2021

Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday...

Via Benzinga

46 Stocks Moving In Thursday's Mid-Day Session ↗

September 02, 2021

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 36% to $9.02 as traders circulate a tweet from popular Twitter trader Will Meade saying 'Long $ANY this is the next $SPRT...

Via Benzinga

INmune Bio Stock Pops As Small-Cap Shows Promise In Alzheimer's Disease ↗

September 02, 2021

INmune Bio said its experimental Alzheimer's drug improved markers of inflammation in the brain, and INMB stock popped Thursday.

Via Investor's Business Daily

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 02, 2021

Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 22.1% to $2.32 during Thursday's pre-market session. The company's market cap stands at $28.0 million....

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

28 Stocks Moving in Thursday's Pre-Market Session ↗

September 02, 2021

Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 39.7% to $26.93 in pre-market trading after jumping 278% on Wednesday. Focus Universal recently priced 2 million shares at $5 per...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 01, 2021

Gainers INmune Bio (NASDAQ:INMB) shares ...

Via Benzinga

Why Are Shares Of INmune Bio Trading Higher Wednesday Afternoon? ↗

September 01, 2021

INmune Bio, Inc. (NASDAQ: INMB) shares traded higher Wednesday afternoon following data out of a trial for the company's Alzheimer's drug candidate. The company said its...

Via Benzinga

10 Stocks Moving In Wednesday's After-Hours Session ↗

September 01, 2021

Gainers INmune Bio (NASDAQ: INMB) shares are trading higher after the company announced XPro has been found to decrease multiple species of Phospho Tau and improve neuroimaging...

Via Benzinga

The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In A Light Week ↗

August 29, 2021

Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and...

Via Talk Markets

The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week ↗

August 29, 2021

Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) and BioNTech SE (...

Via Benzinga

INmune Bio Stock Jumps On Promising Biomarker Data From Early-Stage Blood Cancer Trial ↗

August 26, 2021

INmune Bio Inc (NASDAQ: INMB) announced that the first patient who received INKmune has successfully shown NK activation and functional differentiation. INKmune is...

Via Benzinga

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Featured Local Savings

Sections

News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features
Announcements

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Borger News-Herald

BorgerNewsHerald.com
207 N. Main Street
Borger, TX 79008
Phone: 806-273-5611
Email: editor@borgernewsherald.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Borger, TX (79008)

Today

Tonight

INmune Bio Inc. - Common stock (NQ:INMB)

All News about INmune Bio Inc. - Common stock

Featured Local Savings

Sections

Services

Borger News-Herald